208 Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies
Kim Papp, Jacek C. Szepietowski, Leon Kircik, D. Toth, Lawrence F. Eichenfield, Seth Forman, Michael E. Kuligowski, May E. Venturanza, Kang Sun, Eric L. Simpson
Topics & Concepts
Atopic dermatitisMedicineRuxolitinibAdverse effectBody surface areaInternal medicineJanus kinaseRandomized controlled trialDermatologyMyelofibrosisBone marrowCytokineDermatology and Skin DiseasesAllergic Rhinitis and SensitizationAsthma and respiratory diseases